UBS Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$150M Buy
10,506,691
+6,066,677
+137% +$86.6M 0.03% 564
2025
Q1
$46.6M Buy
4,440,014
+274,735
+7% +$2.88M 0.01% 1211
2024
Q4
$50.4M Buy
4,165,279
+2,294,012
+123% +$27.8M 0.01% 1113
2024
Q3
$27.5M Sell
1,871,267
-40,394
-2% -$593K 0.01% 1109
2024
Q2
$27.6M Buy
1,911,661
+718,850
+60% +$10.4M 0.01% 1045
2024
Q1
$19.4M Buy
1,192,811
+75,615
+7% +$1.23M ﹤0.01% 1215
2023
Q4
$16.6M Buy
1,117,196
+435,291
+64% +$6.49M 0.01% 1191
2023
Q3
$7.66M Buy
681,905
+299,166
+78% +$3.36M ﹤0.01% 1562
2023
Q2
$3.85M Buy
382,739
+155,203
+68% +$1.56M ﹤0.01% 2114
2023
Q1
$2.14M Sell
227,536
-341,402
-60% -$3.21M ﹤0.01% 2539
2022
Q4
$6.95M Buy
568,938
+373,337
+191% +$4.56M ﹤0.01% 1590
2022
Q3
$2.43M Buy
195,601
+28,134
+17% +$349K ﹤0.01% 2221
2022
Q2
$3.29M Sell
167,467
-51,138
-23% -$1M ﹤0.01% 2054
2022
Q1
$5.7M Sell
218,605
-37,234
-15% -$971K ﹤0.01% 1827
2021
Q4
$7.26M Sell
255,839
-1,433,714
-85% -$40.7M ﹤0.01% 1793
2021
Q3
$53.9M Buy
1,689,553
+490,239
+41% +$15.6M 0.02% 620
2021
Q2
$41.6M Buy
1,199,314
+384,875
+47% +$13.4M 0.01% 721
2021
Q1
$24M Buy
814,439
+220,771
+37% +$6.5M 0.01% 966
2020
Q4
$18.2M Sell
593,668
-12,057,629
-95% -$370M 0.01% 1053
2020
Q3
$353M Buy
12,651,297
+1,604,867
+15% +$44.8M 0.13% 128
2020
Q2
$237M Buy
11,046,430
+10,598,327
+2,365% +$227M 0.1% 167
2020
Q1
$10M Sell
448,103
-183,090
-29% -$4.1M ﹤0.01% 1100
2019
Q4
$18.6M Buy
631,193
+190,657
+43% +$5.61M 0.01% 1109
2019
Q3
$11.7M Sell
440,536
-285,826
-39% -$7.6M ﹤0.01% 1289
2019
Q2
$24.6M Buy
726,362
+318,787
+78% +$10.8M 0.01% 859
2019
Q1
$13.1M Buy
407,575
+399,949
+5,245% +$12.8M 0.01% 1186
2018
Q4
$241K Sell
7,626
-1,142
-13% -$36.1K ﹤0.01% 3992
2018
Q3
$306K Buy
+8,768
New +$306K ﹤0.01% 3946